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ZIKA VIRUS: COLLECTION AND SUBMISSION OF 
SPECIMENS FOR ZIKA VIRUS TESTING AT TIME OF BIRTH
General Information 
Laboratory testing for congenital Zika virus infection is recommended for infants born to mothers with laboratory 
evidence of Zika virus infection during pregnancy, and for infants who have abnormal clinical findings suggestive of 
congenital Zika virus syndrome and a maternal epidemiologic link suggesting possible transmission, regardless of 
maternal Zika virus test results. 
For infants born to mothers with risk factors for maternal Zika virus infection (travel to or residence in an area of Zika 
virus transmission or sex with a partner with travel to or residence in such an area) for whom maternal testing was not 
performed before delivery, assessment of the infant, including comprehensive physical exam and careful measurement of 
head circumference should be performed. Maternal diagnostic testing should be performed and testing of the placenta 
for Zika virus PCR should be considered. If an infant appears clinically well, further evaluation and infant testing can be 
deferred until maternal test results are available. However, if there is concern about infant follow-up, infant testing should 
be performed before hospital discharge.
IMPORTANT: Pre-approval is required prior to submission of any placental or other tissue 
specimens. For pre-approval please contact pathology@cdc.gov and eocevent189@cdc.gov. 
Healthcare Providers: 
• Please contact your state, tribal, local, or territorial health department to facilitate laboratory testing and pathology 
specimen submission.
 » If available in your hospital/institution, please consult surgical pathology to ensure appropriate collection and processing 
of tissue specimens for Zika virus testing.
 » Please see table below for information on collection of specimens for Zika virus testing. 
• Specimens should ONLY be sent to CDC directly from health departments. CDC’s Zika Pregnancy Hotline (770-488-
7100) is available 24/7 to healthcare providers and health departments for consultation regarding management of pregnant 
women and infants with possible Zika virus. This hotline can also assist with questions regarding specimen submission. 
Healthcare providers and state and local health officials can call our CDC Watch desk at 770-488-7100 (ask for CDC Zika 
Pregnancy Hotline) or email zikapregnancy@cdc.gov.  
Health Departments: 
• When submitting specimens, please submit CDC Form 50.34 with all specimens. For test order name, write “Zika virus”.
• Pre-approval is required prior to submission of all tissue specimens (i.e., placenta, umbilical cord). Please contact 
pathology@cdc.gov and eocevent189@cdc.gov to discuss the case and obtain pre-approval. If you have additional 
questions for the Infectious Diseases Pathology Branch, please call 404-639-3133.
• If you have additional questions for the Arboviral Diseases Branch, please call 970-221-6400.
Reporting of Results:
• Test results will be reported to the state health department and the submitting healthcare provider. Results will not be 
directly released to patients.
• Turnaround time will depend on testing volume and established reporting systems.
August 18, 2016 CS268552B
CDC’s Response to Zika
Specimen Type General  Instructions Notes Storage Shipping
Infant serum
At least 1.0 ml 
Transfer serum 
to a plastic 
tube measuring 
approximately 50 
mm tall and 15 mm in 
diameter (e.g., 1.8 mL 
cryotube or 2.0 mL 
microtube) with screw 
cap and secure with 
thermoplastic, self-
sealing lab film.
For antibody and 
rRT-PCR testing, 
specimens should be 
kept cold (2–6 °C) or 
frozen (-70 °C).
For virus isolation 
testing, specimens 
should be frozen  
as soon as possible 
(-70 °C).
For cold specimens, 
the sample should be 
placed in an insulated 
container with 
adequate ice packs 
to ensure specimen 
(“cold chain”) 
integrity. 
For frozen specimens, 
ship the sample on 
enough dry ice to 
ensure specimens 
remain frozen until 
received.
Arboviral Diseases 
Branch Diagnostic 
Laboratory 
Centers for Disease 
Control and Prevention 
3156 Rampart Road 
Fort Collins, Colorado 
80521
More information about 
collecting, handling, 
and shipping is 
available here.
Placenta and fetal 
membranes
Several full thickness 
pieces including at 
least 3 full thickness 
pieces (0.5–1 cm 
x 3–4 cm in depth) 
from middle third of 
placental disk and 
at least 1 from the 
placental disk margin
5 x 12 cm strip of fetal 
membranes
Please include 
sections of the 
placental disk, fetal 
membranes, and 
pathologic lesions 
when possible. 
Please include 
information about 
placenta weight and 
sample both maternal 
and fetal side of the 
placenta.  
Label all specimens 
to identify location of 
sample.
Fix specimens in 
formalin
Volume of formalin 
used should be about 
10x mass of tissue. 
Place in 10% neutral 
buffered formalin 
for a minimum of 3 
days. Once fully fixed 
the tissue can be 
transferred to 70% 
ethanol for long term 
storage.  
Storage and shipping 
at room temperature.
Infectious Diseases 
Pathology Branch 
Centers for Disease 
Control and Prevention 
1600 Clifton Rd. NE, 
MS G-32 
Atlanta GA 30329-4027
More instructions can 
be found here.
Umbilical cord
2.5 cm segments of 
cord 
4 or more specimens
Umbilical cord 
segments should be 
obtained proximal, 
middle, and distal 
to umbilical cord 
insertion site on the 
placenta.
Label all specimens 
to identify location of 
sample.
Fix specimens in 
formalin
Volume of formalin 
used should be about 
10x mass of tissue. 
Place in 10% neutral 
buffered formalin 
for a minimum of 3 
days. Once fully fixed 
the tissue can be 
transferred to 70% 
ethanol for long term 
storage.  
Storage and shipping 
at room temperature.
Infectious Diseases 
Pathology Branch 
Centers for Disease 
Control and Prevention 
1600 Clifton Rd. NE, 
MS G-32 
Atlanta GA 30329-4027
More instructions can 
be found here.
